Welcome to the website of PSYRES The Czech Psychedelic Research Foundation. The mission of the foundation is to provide financial support to Czech scientific projects and workplaces that deal with innovative treatment procedures in the field of mental illnesses. Psychotherapy assisted by psychedelics naturally belongs among these procedures.
In our country, the public knows some of the history of the research into these substances. However, psychedelic substances attracted attention in the Czech scientific community much earlier than is realized by most . As early as the 19th century, the Czech physiologist, anatomist, biologist, poet and philosopher Jan Evangelista Purkyně experimented with the effects of nutmeg and belladonna. Before the Second World War, the Czech psychiatrist, psychopathologist, and medical psychologist Svetozar Nevole published a study on mescaline and studied its effect on human mental activity.
Psychoactive substances were later experimented with by one of the founders of transpersonal psychology, American psychiatrist of Czech origin Stanislav Grof, associate professor of the Department of Psychiatry at the Faculty of Medicine in Prague, Jiří Roubíček, and the research group of psychiatrist Miloš Vojtěchovský, who in the 1960s studied psychedelics for their use in psychotherapy and kept Czechoslovakia on the cutting edge of this research. Similarly, Milan Hausner, head of the psychiatric hospital in Sadská, which, with one hundred beds under his leadership, became the largest clinic using LSD not only in the country, but also in all of Europe, also played an important role.
The investigation of the potential of psychedelics was subsequently suspended worldwide for four decades, therefore the promising research is experiencing a welcomed renaissance in the new millennium. The task of the PSYRES Foundation is therefore to support research and study of psychedelic substances and their use in pharmacology, psychology, addictology and psychiatry.
Our activity helps with the preparation and implementation of clinical studies and analyses. We organise educational events as well. We collaborate with doctors, therapists and researchers who deal in depth with altered states of human consciousness. Among our partners you will find important Czech and international institutions.
However, we are actively looking for sympathisers of the extremely promising Czech psychedelic research not only among philanthropists, but also among the general public. We are convinced that the use of these substances in clinical medicine will bring about a fundamental change in the approach to the treatment of mental illnesses and it will provide new knowledge about the essence of human consciousness which is so valuable for the whole society.
You can find contact information, annual reports and other documents here.
20 years ago, a personal story brought Jana to the issue of mental illnesses and their treatment. Her interest and belief in the wide-spectrum healing potential of psychedelics is the driving force behind everything she does. She brings 20 years of experience in project management, marketing, communication and customer care to PSYRES.
He has over two decades of experience in advertising, marketing and visual identity development. He was brought to PSYRES by a long-standing interest in the therapeutic potential of psychedelic substances, combined with his trust in the country's leading experts on the subject.
Addictologist, student of the doctoral program at the Faculty of Philosophy and Addictology Clinic of Charles University. She focuses on the ritual use of psychedelics in the Czech context. Co-founder of the Czech Psychedelic Society, organizer of psychedelic-themed events, and media representative of psychedelic research at the National Institute of Mental Health.
Neuroscientist, psychiatrist, psychotherapist, and head of the Department of Psychiatry and Medical Psychology at 3rd Faculty of Medicine, Charles University. His research at the University and at the National Institute of Mental Health deals with the study of the therapeutic potential of psychedelics, research into schizophrenia, the theory of consciousness, and the use of neuroimaging methods. Co-founder of Psyon Clinic.
Psychiatrist and neuroscientist specializing in research into the effects of psychedelics and other psychoactive substances. Head of the Psychedelic Research Center at the National Institute of Mental Health. His teams' research covers areas ranging from cell cultures to the use of psychedelics in the treatment of depressed patients. Co-founder of Psyon Clinic.
Neuroscientist, neurologist, and head of the Clinical Research Program of the National Institute of Mental Health. He focuses on the application of neuroimaging methods (especially quantitative electroencephalography) in the evaluation of the effects of psychoactive substances on the central nervous system with the aim of improving the prediction of response to psychopharmacological treatment. Co-founder of Psyon Clinic.
Společnost pro podporu neurovědního výzkumu s.r.o.,
V Honech 687, 250 67 Klecany, IČO: 05547130
Economist and philanthropist, investor in financial and private equity projects around RSJ. Co-owner of the contemporary art center Dox Prague and occasional producer. He likes to engage in disruptive ideas. He is convinced of the fundamental societal significance of the psychedelic renaissance.
Entrepreneur and adventurer (travelled the world with a backpack). He founded several successful companies such as Mall.cz. Through his investment fund Reflex Capital, he invests in promising Czech projects and entrepreneurs. He and his wife Tereza are raising three children and together they support non-profit activities with a social impact.
Multidisciplinary creator, founder and CEO of JAD Production. Dancer, choreographer, director, producer and actor. One of the most sought after creatives in the industry. He has collaborated with renowned artists and produces his own projects and brands.
Bioorganic Chemist. He has been involved in forensic toxicology and neuropsychopharmacological research for more than 10 years. In the field of psychedelic substances, he focuses on the synthesis of alkaloids, their metabolism and pharmacological characterization with a hope for their use in psychiatric practice. Active member of the International Forensic Toxicology Society. He transfers current scientific knowledge to the legislation on narcotic and psychotropic substances.
Doctor specializing in hygiene and epidemiology. Doctor of preventive medicine at the 1st Faculty of Medicine of Charles University and docent of the Addictology Clinic. Former head of the National Monitoring Center for Drugs and Drug Addiction at the Government Office. He published a number of scientific and conceptual works in the field of epidemiology of legal and illegal drugs, and gambling.
Psychologist specializing in psychedelic harm reduction and integration. Co-founder of the psychedelic education company Fluence, training specialists in assisted psychedelic therapy. Researcher and clinical research therapist of MDMA-assisted psychotherapy for PTSD.
Psychologist specializing in Gestalt psychotherapy. She works as a therapist in Milan, Italy and in Switzerland, where she deepens her practice in bio-natural disciplines. Her leading research is situated in South America in indigenous communities. She studies traditional medicine, plants, and healing rituals. She participates in research using plants in collaboration with universities in Central Europe, the United States, and South America. In Italy, she promotes the use of psychotropic substances in therapy.
Professor of Psychopharmacology and Behavioral Toxicology. He works at Maastricht University in the Netherlands. He is engaged in research in the field of psychopharmacology, addictions, drugs, and traffic psychology.
Are you interested in news from psychedelic research or news from the fund's activities? Subscribe to the newsletter!